期刊文献+

药物研发方面诱导多能干细胞的应用分析

Analysis on the Application of Induced Pluripotent Stem Cells in Drug Research and Development
下载PDF
导出
摘要 再生医学领域研究工作近年来不断深入,目前诱导多能干细胞具有的多组织潜能在药物研发中的应用价值也被不断挖掘出来。基于多能干细胞药物研发技术现状,文章首先分析了多能干细胞产生技术的主要技术内容,其次对药物研发方面诱导多能干细胞的应用途径与模式进行了阐述和分析,希望可以为多能干细胞在药物研发方面治疗与应用提供更为丰富的经济价值与应用价值。 In recent years,the research work in the field of regenerative medicine has continued to deepen.At present,the application value of multi-organizational potential in induced pluripotent stem cells in drug research and development has also been explored.Based on the current situation of pluripotent stem cell drug research and development technology,this paper first analyzes the main technical content of pluripotent stem cell production technology,and then expounds and analyzes the application ways and modes of inducing pluripotent stem cells in drug research and development,hoping to provide more economic value and application value for the treatment and application of pluripotent stem cells in drug research and development.
作者 魏喆 Wei Zhe(Tianjin Onsai Cell Genetic Engineering CO.,LTD.,Tianjin,300457)
出处 《当代化工研究》 2019年第1期174-175,共2页 Modern Chemical Research
关键词 药物研发 多能干细胞 应用分析 drug research and development pluripotent stem cells application and analysis
  • 相关文献

参考文献3

二级参考文献31

  • 1Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126(4): 663-676.
  • 2Adewumi O, Aflatoonian B, Ahrlund-Richter L, et ol. Character- ization of human embryonic stem cell lines by the International Stem Cell Initiative[J]. Nat Biotechnol, 2007, 25(7): 803-816.
  • 3I Takahashi K, Tanabe K, Ohnuki M, et ol. Induction of pluripo- tent stem cells from adult human fibroblasts by defined factors [J]. Cell, 2007, 131(5): 861-872.
  • 4Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of ind- uced pluripotent stem cells without Myc from mouse and hu- man fibroblasts[Jl. Nat Biotechnol, 2008, 26(1): 101-106.
  • 5Yu J, Vodyanik MA, Smuga-Otto K, et ol. Induced pluripotent s- tem cell lines derived from human somatic cells [J]. Science, 2007, 318(5858): 1917-1920.
  • 6Brambrink T, Foreman R, Welstead GG, et ol. Sequential expre- ssion of pluripotency markers during direct reprogramming of mouse somatic cells[J]. Cell Stem Cell, 2008, 2(2): 151-159.
  • 7Zhou H, Wu S, Joo JY, et al. Generation of induced pluripotent s- tem cells using recombinant proteins[J]. Cell Stem Cell, 2009, 4 (8): 381-384.
  • 8Stadtfeld M, Nagaya M, Utikal J, et ol. Induced pluripotent stem cells generated without viral integration [J]. Science, 2008, 322: 945-949.
  • 9Okita K, Nakagawa M, Hyenjong H, et ol. Generation of mouse i- nduced pluripotent stem cells without viral vectors[J]. Science, 2008, 322(5903): 949-953.
  • 10Soldner F, Hockemeyer D, Beard C, et al. Parkinson' s disease p-atient-derived induced pluripotent stem cells free of viral repro- gramming factor[J]. Cell, 2009, 136(5): 964-977.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部